Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/09/2013EP2647378A1 Steroid sulfatase inhibitor regimen for the treatment of endometriosis
10/09/2013EP2647377A1 Use of an h3 receptor antagonist for the treatment of alzheimer's disease
10/09/2013EP2647376A1 Nuclear receptor binding agents
10/09/2013EP2647375A1 Combination of vargatef and dabigatran for the treatment of oncological and fibrotic diseases
10/09/2013EP2647374A1 Nutritional compositions including beta-hydroxy-beta-methylbutyrate for regulating transcription factors
10/09/2013EP2647373A1 Methods for preventing the development of retinopathy by the oral administration of exo-S-mecamylamine.
10/09/2013EP2647372A1 Monoterpenes for treating respiratory tract diseases, in particular bronchopulmonary diseases
10/09/2013EP2647371A1 A transmucosal delivery system
10/09/2013EP2647370A1 Transfusion preparation
10/09/2013EP2647369A1 Use of pacap for treating viral infections in aquatic organisms
10/09/2013EP2646577A2 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents
10/09/2013EP2646555A1 Methods and pharmaceutical compositions for the treatment of heart failure
10/09/2013EP2646553A1 Compositions and methods for treating androgen receptor dependent disorders including cancers
10/09/2013EP2646477A1 Glucan compositions
10/09/2013EP2646476A1 Glucan gels
10/09/2013EP2646475A1 Glucans
10/09/2013EP2646457A1 Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
10/09/2013EP2646456A1 Process for the preparation of morpholinyl anthracycline derivatives
10/09/2013EP2646455A2 Modulators of histone methyltransferase, and methods of use thereof
10/09/2013EP2646454A2 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
10/09/2013EP2646453A1 Compounds
10/09/2013EP2646451A2 Heptose derivatives for use in the treatment of bacterial infections
10/09/2013EP2646449A1 Uridine di- or tri-phosphate derivatives and uses thereof
10/09/2013EP2646448A1 Macrocyclic kinase inhibitors
10/09/2013EP2646446A2 Bromodomain inhibitors and uses thereof
10/09/2013EP2646445A1 Oxazolo [5, 4 -b]pyridin- 5 -yl compounds and their use for the treatment of cancer
10/09/2013EP2646444A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
10/09/2013EP2646443A1 Kat ii inhibitors
10/09/2013EP2646441A2 Carbocycle-substituted purine and 7-deazapurine compounds
10/09/2013EP2646440A2 Hybrid cyclic libraries and screens thereof
10/09/2013EP2646439A1 Alkyl amides as hiv attachment inhibitors
10/09/2013EP2646438A1 3-hetaryl-substituted pyrrolo[2,3-b]pyridine derivatives as pdk1 inhibitors
10/09/2013EP2646437A1 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds
10/09/2013EP2646436A1 Monobactams
10/09/2013EP2646435A1 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
10/09/2013EP2646434A1 Pharmaceutical compositions, dosage forms and new forms of the compound of formula (i), and methods of use thereof
10/09/2013EP2646432A1 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
10/09/2013EP2646430A2 Chemokine cxcr4 receptor modulators and used related thereto
10/09/2013EP2646429A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
10/09/2013EP2646428A1 Heterocyclic derivates preparation processes and medical uses thereof
10/09/2013EP2646427A1 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases
10/09/2013EP2646425A1 Indanyloxydihydrobenzofuranylacetic acids
10/09/2013EP2646423A1 Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases
10/09/2013EP2646421A1 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1h-benzo[e][1,4]diazepin-2(3h)-one and other benzodiazepine derivatives
10/09/2013EP2646420A1 Method for the preparation of high-purity pharmaceutical intermediates
10/09/2013EP2646417A1 Kat ii inhibitors
10/09/2013EP2646415A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646409A1 Fingolimod polymorphs and their processes
10/09/2013EP2646405A1 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
10/09/2013EP2646114A1 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646054A1 Methods for treating a tumor using an antibody that specifically binds grp94
10/09/2013EP2646052A2 Lyophilized viral formulations
10/09/2013EP2646051A2 Liquid viral formulations
10/09/2013EP2646045A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease
10/09/2013EP2646044A1 Methods for increasing intracellular activity of hsp70
10/09/2013EP2646040A1 Priming solutions for cardiopulmonary bypass
10/09/2013EP2646039A1 A composition and use thereof in the treatment of anal rhagades
10/09/2013EP2646038A1 New treatments of hepatitis c virus infection
10/09/2013EP2646037A1 Histone inhibition
10/09/2013EP2646036A1 Topical compositions for preserving or restoring the integrity of mucosae
10/09/2013EP2646035A2 Prodrugs of 6-cyclohexyl-1-hydroxy-4- methylpyridin-2(1h)-one and derivatives thereof
10/09/2013EP2646034A1 Methods for treating diseases of the retina
10/09/2013EP2646033A1 Volasertib alone or in combination with cytarabine for treating acute myeloid leukemia
10/09/2013EP2646032A1 Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity or prediabetes
10/09/2013EP2646031A1 Increasing drug bioavailability in naltrexone therapy
10/09/2013EP2646030A1 Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
10/09/2013EP2646029A1 Treatment of jak2-mediated conditions
10/09/2013EP2646028A1 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646027A1 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646026A1 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646025A1 Use of sigma ligands in bone cancer pain
10/09/2013EP2646024A1 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646023A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646022A1 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646021A1 Oxadiazole derivatives as sphingosine 1-phosphate (s1p)receptor modulators
10/09/2013EP2646020A1 Indoles
10/09/2013EP2646019A1 Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
10/09/2013EP2646018A1 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
10/09/2013EP2646017A2 Compounds and methods for skin repair
10/09/2013EP2646016A1 Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
10/09/2013EP2646015A2 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
10/09/2013EP2646014A2 Topical formulations for administration of omega-3 fatty acids
10/09/2013EP2646013A2 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
10/09/2013EP2646012A2 Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
10/09/2013EP2646011A1 Methods for reducing binge or compulsive eating
10/09/2013EP2646010A1 Folic acid - ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions
10/09/2013EP2646009A1 Rotigotine ionic liquid
10/09/2013EP2646008A1 Transdermal therapeutic system (tts) comprising rotigotine
10/09/2013EP2646001A2 Formulation of lacosamide
10/09/2013EP2646000A1 Chemoembolization composition comprising anti-angiogenic agents
10/09/2013EP2645998A2 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
10/09/2013EP2645997A2 Once daily formulation of lacosamide
10/09/2013EP2645996A2 Process for the preparation of a ppi-containing pharmaceutical product
10/09/2013EP2645994A2 Formulations comprising methylthioninium chloride
10/09/2013EP2645993A2 Pharmaceutical cream compositions comprising oxymetazoline
10/09/2013EP2645992A2 Solid dosage form that promotes reliable oral, esophageal and gi transit
10/09/2013EP2645986A2 Anti-dandruff shampoo
10/09/2013EP2645882A1 Use of a food composition in the treatment and/or prevention of neuropathic pain induced by an anticancer agent
10/09/2013EP2645878A1 Prevention or treatment of overweight and obesity in type 2 diabetic patients
10/09/2013EP2645858A1 Electrokinetic device for capturing assayable agents in a dielectric fluid
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 7860